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Summary
Objectives: The purpose of this study was to re-assess the left ventricular (LV)
systolic function in diastolic heart failure (DHF) using Doppler echocardiography.
Background: Systolic function in DHF is deﬁned as the preserved LV ejection fraction
(EF). EF may not fully reﬂect the systolic function in DHF, especially in the presence
of abnormalities during the isovolumetric contraction time (ICT).
Methods: We examined LV systolic and diastolic function in 80 consecutive patients
with DHF, 30 patients with asymptomatic diastolic dysfunction (ADD), and 30 normal
subjects (Control). The LV and left atrial volumes, LV EF, LV ICT, and isovolumetric
relaxation time (IRT), early diastolic mitral ﬂow velocity, systolic mitral annular
velocity (S′), and early diastolic mitral annular velocity were obtained.
Results: LV ICT in DHF (69± 30ms) was signiﬁcantly increased compared to those
with ADD (37± 23ms) and Control (35± 26ms) (P < 0.0001). ICT in ADD was equal
to that in Control. The LV end-diastolic volume index in DHF (49± 14ml/m2) was
signiﬁcantly increased compared to those with ADD (42± 12ml/m2) and Control
(43± 8ml/m2) (P < 0.05). S′ in DHF (5.9± 1.4 cm/s) and ADD (6.7± 1.1 cm/s) was
signiﬁcantly decreased compared to that in Control (8.7± 2.5 cm/s).
∗ Corresponding author. Tel.: +81 99 275 6766; fax: +81 99 275 6748.
E-mail address: akira-k@m2.kufm.kagoshima-u.ac.jp (A. Kisanuki).
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Conclusions: Our results revealed that the major differences between ADD and DHF
were global and longitudinal LV systolic dysfunction and LV enlargement. This study
suggests that LV systolic dysfunction plays an important role in the development of
DHF.
e of Cardiology. Published by Elsevier Ireland Ltd. All rights
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mitral E wave was also measured from its peak to
the time when the descent of the wave intercepted© 2009 Japanese Colleg
reserved.
Introduction
Diastolic heart failure (DHF) reportedly accounts
for approximately 30% of all patients with heart
failure, and the prognosis of DHF was reported to
be better than that of systolic heart failure [1].
However, recently, the number of DHF cases has
increased to about half of congestive heart failure
cases and the mortality and morbidity rates for DHF
and systolic heart failure are nearly equal [2—4].
Systolic function in DHF is deﬁned as the pre-
served left ventricular (LV) ejection fraction (EF)
[1,4]. LVEF has been used as systolic function dur-
ing the ejection time (ET). However, we think that
EF does not fully reﬂect the LV systolic function
in DHF, especially in the presence of abnormalities
during the isovolumetric contraction time (ICT).
DHF involves abnormalities in active relaxation of
LV, which cause a reduction in the pressure gra-
dient between the left atrium and LV in early
diastole [5,6]. Experimental studies suggested that
this left atrium-LV pressure gradient in early dias-
tole was correlated with the peak positive rate
of the LV pressure increase [6,7]. Therefore, we
hypothesized that DHF will show abnormalities of
LV contractility. The purpose of this study was to re-
assess systolic function in DHF using several indices
of LV systolic function, such as ICT, systolic mitral
annular velocity (S′), and EF by employing Doppler
echocardiography.
Methods
Study subjects
The subjects consisted of 80 consecutive patients
with DHF, 30 consecutive patients with asymp-
tomatic diastolic dysfunction (ADD) [8], and 30
age-matched normal subjects (Control). DHF was
diagnosed using the following criteria of the Euro-
pean Society of Cardiology speciﬁed in 2007 [4],
including: (1) signs or symptoms of heart fail-
ure; (2) LVEF > 50% and an LV end-diastolic volume
index < 97ml/m2; and (3) evidence of diastolic dys-
function by tissue Doppler (E/E′ > 15), etc. ADD
was deﬁned as patients without signs, symptoms,
t
a
a
l
Sr a history of congestive heart failure, but with
chocardiographic criteria of diastolic dysfunction
nd the preserved LVEF mentioned above. Control
ubjects showed normal ﬁndings on physical exam-
nation, chest roentgenogram, electrocardiogram,
nd echocardiogram, without a history of cardio-
ascular disease. Patients with atrial ﬁbrillation,
itral or aortic stenosis, moderate/severe mitral or
ortic regurgitation, or severe renal or hepatic fail-
re were excluded from this study. The protocol was
pproved by Kagoshima University Hospital, and
nformed consent was obtained from all subjects.
chocardiographic examination
wo-dimensional and Doppler echocardiographic
xaminations were performed in all subjects using
—5MHz phased array transducers and commer-
ially available equipment (ATL HDI 5000, Bothell,
A, USA; Philips Medical Systems Sonos 5500,
ndover, MA, USA; Aloka SSD-5500, Tokyo, Japan;
ivid 7, GE Medical Systems, Milwaukee, WI, USA).
ll Doppler and echocardiographic measurements
ere performed according to the guidelines of the
merican Society of Echocardiography speciﬁed in
005 [9,10]. LV wall thickness of the septum and
osterior wall was measured in end-diastole using
he parasternal long-axis view. The end-diastolic
nd end-systolic LV volumes and EF were obtained
y the modiﬁed biplane Simpson’s method from the
pical 2- and 4-chamber views. The left atrial vol-
mes were calculated by the area—length method.
he mitral ﬂow velocity was recorded in the api-
al 4-chamber view by placing the sample volume
f the pulsed wave Doppler echocardiography at
he mitral valve tip. The LV outﬂow velocity was
ecorded in the apical long-axis view by placing the
ample volume at the LV outﬂow tract. The early
iastolic (E) and late diastolic mitral ﬂow veloci-
ies were measured. The deceleration time of thehe baseline. Tissue Doppler imagings of the medial
nd lateral mitral annulus were obtained from the
pical 4-chamber view. The early diastolic (E′) and
ate diastolic velocities of the mitral annulus and
′ were measured. These variables were analyzed
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Figure 1 Schematic to measure Doppler cardiac time intervals. a, The interval between the cessation and onset of
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ditral inﬂow, which is the sum of the left ventricular (LV)
nd isovolumetric relaxation time (IRT); b, LV ET; c, inter
nset of mitral inﬂow; d, interval between the R wave on
ndividually as the average of the medial and lateral
ites and E/E′ was calculated [11]. Doppler time
ntervals were measured from the mitral inﬂow and
he LV outﬂow velocities, as shown in Fig. 1. The
nterval a was measured from the cessation of the
itral inﬂow to the onset of the next inﬂow. The
nterval b, ejection time, was measured from the
nset of the LV outﬂow velocity to its cessation. The
V isovolumetric relaxation time (IRT) was obtained
y subtracting the interval d, between the R wave
n the electrocardiogram and the cessation of the
V ejection ﬂow, from the interval c, between the
wave and onset of the mitral inﬂow. LV ICT was
hen obtained by subtracting IRT from (a−b). The
atio of ICT divided by ET (ICT/ET) and that of
RT divided by ET (IRT/ET) were also calculated
Fig. 1) [12—15]. All measurements were performed
rom 3 consecutive beats, and average values were
btained. We further compared systolic function
ndices of S′, ICT, and ICT/ET in each subgroup of
nderlying diseases between ADD and DHF.
tatistical analysis
he results are expressed as the mean± SD. Dif-
erences among groups were tested for signiﬁcance
sing 1-way analysis of variance (ANOVA), with sub-
roup analysis by the Scheffè F test. Comparisons
f non-parametric data were performed using the
hi-square test. Differences between groups were
ested employing the non-paired t-test. A P-value
f less than 0.05 was considered signiﬁcant.
E
T
r
columetric contraction time (ICT), LV ejection time (ET),
etween the R wave on the electrocardiogram (ECG) and
and cessation of LV outﬂow.
esults
ubjects
atient characteristics of the study groups are
resented in Table 1. There were no signiﬁcant
ifferences in the age, gender distribution, body
urface area, and body mass index among the 3
roups. The ADD group consisted of 13 patients
ith hypertensive heart disease, 7 patients with
schemic heart disease, and 10 patients with hyper-
rophic cardiomyopathy. The DHF group consisted
f 22 patients with hypertensive heart disease,
7 patients with ischemic heart disease, and 41
atients with hypertrophic cardiomyopathy.
The New York Heart Association class in ADD was
lass I in all patients. Those in DHF were none in
lass I, 57 in class II, 23 in class III, and none in
lass IV. The heart rate in control subjects was sig-
iﬁcantly higher compared to those with ADD and
HF.
The number of patients receiving beta-blockers
as signiﬁcantly higher in DHF compared to those
n ADD. Twenty-three patients with DHF received
iuretics, and there were no patients receiving
iuretics in ADD (Table 1).chocardiographic data
he LV wall thickness of the septum and poste-
ior wall in ADD and DHF were signiﬁcantly higher
ompared to those in Control. There were no sig-
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Table 1 Patient characteristics.
Control; n = 30 ADD; n = 30 DHF; n = 80
Age (years) 63± 13 63± 13 64± 14
Male/female 15/15 20/10 49/31
BSA (m2) 1.63± 0.18 1.66± 0.17 1.64± 0.17
BMI (m2) 23.6± 2.6 23.1± 3.1 23.5± 3.4
Underlying disease
HHD 0 13 (43%) 22 (28%)
IHD 0 7 (23%) 17 (21%)
HCM 0 10 (33%) 41 (51%)
NYHA
Class I/II/III/VI — 30/0/0/0 0/57/23/0
Heart rate (bpm) 72± 12 64± 11* 64± 12†
Comorbidities (%)
Diabetes mellitus 3 (10%) 8 (26%) 22 (28%)
Hypertension 0 20 (66%)‡ 59 (74%)‡
Medications (%)
Beta-blockers 0 12 (40%)‡ 53 (66%)‡,§
ACEI or ARB 0 18 (60%)‡ 44 (55%)‡
Diuretics 0 0 (0%) 23 (28%)‡,#
Calcium antagonists 0 13 (43%)‡ 36 (45%)†
ACEI, Angiotensin-converting enzyme inhibitor; ADD, asymptomatic diastolic dysfunction; ARB, angiotensin receptor blocker; BMI,
body mass index; BSA, body surface area; DHF, diastolic heart failure; HCM, hypertrophic cardiomyopathy; HHD, hypertensive
heart disease; IHD, ischemic heart disease; NYHA, New York Heart Association.
* P < 0.05 relative to Control.
† P < 0.01 relative to Control.
‡ P < 0.001 relative to Control.
differences in ICT and ICT/ET between Control and
ADD. However, ICT and ICT/ET in DHF were sig-
niﬁcantly increased compared to those in Control
and ADD (Table 3 and Fig. 4). IRT and IRT/ET in
Figure 2 Comparison of the left ventricular end-§ P < 0.01 relative to ADD.
# P < 0.001 relative to ADD.
niﬁcant differences in the LV end-diastolic volume
index and LV end-systolic volume index between
Control and ADD. However, the LV end-diastolic
volume index and LV end-systolic volume index
in DHF were signiﬁcantly increased compared to
those in Control and ADD (Fig. 2). EF did not
differ signiﬁcantly among the 3 groups. The left
atrial volume index in ADD and DHF was signiﬁ-
cantly increased compared to that in Control. E
velocities in DHF were signiﬁcantly higher than
those in Control and ADD. E′ velocities in ADD
and DHF were signiﬁcantly decreased compared to
those in Control. E/E′ in ADD and DHF was sig-
niﬁcantly higher than that in Control. E/E′ was
not signiﬁcantly different between ADD and DHF.
S′ in ADD and DHF was signiﬁcantly decreased
compared to that in Control. S′ in DHF was signiﬁ-
cantly decreased compared to that in ADD (Table 2
and Fig. 3).Cardiac time interval data
ET in ADD was signiﬁcantly increased compared to
that in DHF and Control. There were no signiﬁcant
diastolic volume index among the 3 groups. The left
ventricular end-diastolic volume index (LVEDVI) in dias-
tolic heart failure (DHF) was signiﬁcantly increased
compared to that in Control and asymptomatic diastolic
dysfunction (ADD).
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Table 2 Echocardiographic data.
Control; n = 30 ADD; n = 30 DHF; n = 80
Septal wall thickness (mm) 10 ± 1 18 ± 5* 17 ± 5*
PW thickness (mm) 10 ± 1 12 ± 2† 12 ± 2*
LVEDVI (ml/m2) 43 ± 8 42 ± 12 49 ± 14‡,§
LVESVI (ml/m2) 14 ± 4 14 ± 6 18 ± 8†,§
EF (%) 67 ± 5 67 ± 6 64 ± 8
LAVI (ml/m2) 22 ± 8 35 ± 14* 38 ± 16*
Mitral Doppler ﬂow
E (cm/s) 59 ± 13 62 ± 16 70 ± 21†
A (cm/s) 72 ± 20 75 ± 21 73 ± 26
DT (ms) 215 ± 49 244 ± 65 216 ± 70
Tissue Doppler imaging
E′ (cm/s) 8.7 ± 2.5 3.8 ± 1.1* 4.4 ± 1.4*
E/E′ 7.1 ± 2.4 16.8 ± 4.5* 17.3 ± 10.3*
S′ (cm/s) 8.4 ± 3.0 6.7 ± 1.1† 5.9 ± 1.5*,§
A, Late diastolic mitral ﬂow velocity; ADD, asymptomatic diastolic dysfunction; BSA, body surface area; DHF, diastolic heart failure;
DT, deceleration time; E, early diastolic mitral ﬂow velocity; E′, early diastolic mitral annular velocity; EF, ejection fraction; LAVI,
left atrial volume index; LVEDVI, left ventricular end-diastolic volume index; LVESVI, left ventricular end-systolic volume index;
PW, posterior wall; S′, systolic mitral annular velocity.
* P < 0.001 relative to Control.
† P < 0.01 relative to Control.
‡ P < 0.05 relative to Control.
§ P < 0.05 relative to ADD.
ADD and DHF were signiﬁcantly increased compared
to those in Control. There were no signiﬁcant dif-
ferences in IRT and IRT/ET between ADD and DHF
(Table 3). A representative ADD patient with nor-
mal ICT and a DHF patient with increased ICT are
shown in Figs. 5 and 6. Both patients showed an
equally increased IRT.
Figure 3 Comparison of the systolic mitral annular
velocity (S′) among the 3 groups. S′ in both asymptomatic
diastolic dysfunction (ADD) and diastolic heart failure
(DHF) was signiﬁcantly decreased compared to that in
Control. A signiﬁcant decrease of S′ was noted in DHF
compared to that in ADD.
Figure 4 Comparison of the isovolumetric contraction
time (ICT) among the 3 groups. ICT in diastolic heart fail-
ure (DHF) was signiﬁcantly increased compared to that
i
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Dn Control and asymptomatic diastolic dysfunction (ADD).
here were no signiﬁcant differences in ICT between Con-
rol and ADD.
omparison of systolic function in each
ubgroup of underlying diseases between
DD and DHF
here were no signiﬁcant differences in S′ between
DD and DHF in each of the subgroups, respec-
ively. ICT in hypertensive heart disease patients
nd hypertrophic cardiomyopathy patients with
HF was signiﬁcantly increased compared to those
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Table 3 Cardiac time interval data.
Control; n = 30 ADD; n = 30 DHF; n = 80
ET (ms) 282 ± 31 304 ± 28*,† 284 ± 37
ICT (ms) 35 ± 26 37 ± 22 69 ± 30‡,§
ICT/ET 0.12 ± 0.09 0.12 ± 0.07 0.24 ± 0.11‡,§
IRT (ms) 88 ± 31 125 ± 31‡ 114 ± 31#
IRT/ET 0.31 ± 0.11 0.42 ± 0.10# 0.41 ± 0.13#
ADD, Asymptomatic diastolic dysfunction; DHF, diastolic heart failure; ET, ejection time; ICT, isovolumetric contraction time; IRT,
isovolumetric relaxation time.
* P < 0.01 relative to Control.
† P < 0.01 relative to DHF.
L
c
A
(
c
f
o‡ P < 0.0001 relative to Control.
§ P < 0.0001 relative to ADD.
# P < 0.001 relative to Control.
with ADD. ICT/ET in each of the subgroups with DHF
was signiﬁcantly increased compared to those with
ADD (Table 4).
DiscussionIn this study, we clariﬁed that (1) LV ICT and ICT/ET
in DHF were signiﬁcantly increased compared to
those in Control and ADD; (2) the reduction in
S′ was more severe in DHF than in ADD; (3) the
p
f
o
t
Figure 5 Two-dimensional long axis (A) and pulsed wave Dopp
velocity (C) echocardiograms in a patient with hypertensive he
isovolumetric contraction time (ICT) was normal and the isovo
for details). Ao, Aorta; LA, left atrium; LV, left ventricle; RV,V end-diastolic volume index in DHF was signiﬁ-
antly increased compared to those in Control and
DD, although it was within the criteria of DHF
<97ml/m2). We have demonstrated that signiﬁ-
antly impaired global and longitudinal LV systolic
unction, especially abnormalities during ICT, were
bserved in patients with DHF compared to those in
atients with ADD, suggesting that LV systolic dys-
unction plays an important role in the development
f DHF. LV enlargement in DHF appears to indicate
he transition from concentric remodeling caused
ler mitral inﬂow velocity (B) and left ventricular outﬂow
art disease and asymptomatic diastolic dysfunction. The
lumetric relaxation time (IRT) was increased (see Fig. 1
right ventricle.
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Figure 6 Two-dimensional long axis (A) and pulsed wave Doppler mitral inﬂow velocity (B) and left ventricular outﬂow
v e he
c . 1 f
R
b
[
telocity (C) echocardiograms in a patient with hypertensiv
ontraction and relaxation times were increased (see Fig
V, right ventricle.y the progression of global systolic dysfunction
16—18].
In our study, 50% of patients with DHF had hyper-
rophic cardiomyopathy, because our hospital was
a
T
t
o
Table 4 Systolic parameters in each subgroup of underlyin
ADD; n = 30
S′ (cm/s)
HHD 6.7± 1.2 (n = 13)
IHD 7.3± 0.7 (n = 7)
HCM 6.2± 1.1 (n = 10)
ICT (ms)
HHD 31± 22 (n = 13)
IHD 39± 23 (n = 7)
HCM 42± 22 (n = 10)
ICT/ET
HHD 0.10± 0.08 (n = 13)
IHD 0.12± 0.07 (n = 7)
HCM 0.14± 0.07 (n = 10)
ADD, Asymptomatic diastolic dysfunction; DHF, diastolic heart failure
hypertensive heart disease; ICT, isovolumetric contraction time; IH
* P < 0.001 relative to ADD.
† P < 0.01 relative to ADD.
‡ P < 0.05 relative to ADD.art disease and diastolic heart failure. Both isovolumetric
or details). Ao, Aorta; LA, left atrium; LV, left ventricle;local center for patients with cardiomyopathy.
he ratio of the septal wall thickness to the pos-
erior wall thickness was >1.3, which is a criteria
f asymmetric septal hypertrophy. Therefore, we
g disease between ADD and DHF.
DHF; n = 80
6.1± 1.7 (n = 22)
6.6± 1.4 (n = 17)
5.5± 1.4 (n = 41)
74± 36 (n = 22)*
58± 26 (n = 17)
71± 28 (n = 41)†
0.25± 0.13 (n = 22)*
0.21± 0.09 (n = 17)‡
0.25± 0.10 (n = 41)†
; ET, ejection time; HCM, hypertrophic cardiomyopathy; HHD,
D, ischemic heart disease; S′, systolic mitral annular velocity.
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compared LV systolic function in the subgroups
of underlying disease between ADD and DHF to
assess the inﬂuence of this high frequency of hyper-
trophic cardiomyopathy patients on our results.
Consequently, we did not observe any signiﬁcant
differences in the subgroup analysis results com-
pared to those in the total patient analysis.
The heart rate in ADD and DHF was signiﬁcantly
decreased compared to that in Control, probably
due to beta-blocker administration to patients with
both ADD and DHF. The increase of ET in ADD
seemed to be the inﬂuence of this bradycardia.
The additional decrease of ET in DHF may have
been caused by the signiﬁcant prolongation of ICT
in this group. We compared LV ICT between patients
receiving and not receiving beta-blockers to assess
the inﬂuence of beta-blockers on ICT in patients
with DHF, resulting in the ﬁnding of no inﬂuences
of beta-blockers on ICT. Diastolic function assessed
by the deceleration time of mitral E wave and tis-
sue Doppler E′ and E/E′ were equally disturbed in
ADD and DHF.
Re-assessment of systolic function in DHF
LV systolic function in DHF has been solely eval-
uated by EF. Systolic function in DHF has been
deﬁned as normal or slightly abnormal (EF > 50%)
[1,4]. However, we believe that the process of LV
contraction is more complicated than is generally
thought. LVEF is the most commonly used index of
systolic function that reﬂects the changing ratio of
the LV volume during ET. We think that LV systolic
function should not be evaluated by EF alone. In our
study, we assessed the global LV systolic function
by ICT and EF, and the local longitudinal LV systolic
function by tissue Doppler S′. LV ICT is an estab-
lished index of LV contractility that correlates with
the peak positive rate of LV pressure increase [14].
ICT also inﬂuences active LV relaxation [6]. LV ICT
could not be obtained easily by an invasive method
in clinical human studies, because 3 pressure curves
of LV, the left atrium, and aorta were required
without time delay. LV ICT was measured nonin-
vasively using a phonocardiogram and the carotid
pulse in 1962 [12—15,19—22]. M-mode echocardio-
graphy was developed for the measurement of LV
ICT, measured from echocardiograms of mitral and
aortic valves. Hirschfeld et al. demonstrated the
usefulness of LV ICT for assessing systolic LV per-
formance in various heart diseases using M-mode
echocardiography [20]. Pulsed Doppler echocardio-
graphy progressed the measurements of LV ICT,
because it demonstrated the beginning and end of
mitral and aortic ﬂow more clearly compared to
M-mode echocardiography or phonocardiography.
D
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umoto et al. and Satoh et al. reported experimen-
al studies on the reliability of Doppler LV ICT as
n index of fetal cardiac contractility [21,22]. We
ave reported the usefulness of ICT measured by
oppler echocardiography as an index of cardiac
ontractility [12—15].
There have been several studies that reported
ongitudinal LV systolic abnormalities in DHF using
issue Doppler imaging, which was also observed in
ur study [8,23—26]. The reason for the preserved
VEF in spite of longitudinal systolic dysfunction has
een thought to be that EF expressed mainly LV
adial systolic function [26]. Yu et al. clariﬁed the
rogression of LV systolic abnormalities assessed by
issue Doppler imaging in patients with an isolated
iastolic dysfunction, which was the same criteria
s for our ADD, and DHF [25]. They suggested the
mportance of LV systolic dysfunction in the devel-
pment of DHF from ADD. However, they did not
ssess the cardiac time interval and LV volume.
ecently, Nishikage et al. reported [27] that lon-
itudinal LV systolic dysfunction was observed in
symptomatic patients with hypertensive heart dis-
ases, which is similar to the results of longitudinal
V systolic dysfunction in our ADD patients.
Baicu et al. published echocardiographic and
ardiac catheterization data showing no abnormal-
ties in LV systolic function in patients with DHF
28]. Their patients had a history of heart fail-
re. It was unclear whether or not their patients
xperienced heart failure at the time of exami-
ations. In addition, medications administered to
heir patients were not clariﬁed. We think that the
riteria of DHF of Baicu et al. were different from
urs, and that their patients were similar to our ADD
atients. Aurigemma et al. thought that the lon-
itudinal LV systolic abnormalities in patients with
HF were subtle and unlikely to be responsible for
eart failure in DHF, because the number of patients
ith such abnormalities was small [29]. Indeed, not
ll patients with DHF exhibited LV systolic function
bnormalities in our study. We cannot explain the
echanism of heart failure in our DHF patients with
normal LV systolic function at the present time.
owever, signiﬁcant differences in global and longi-
udinal LV systolic functional abnormalities in DHF
ere evident in our study, and several data have
ointed out the longitudinal LV systolic dysfunction
n DHF. Thus, LV systolic dysfunction appears to be
ne of the important factors participating in the
echanism of heart failure in DHF.iastolic dysfunction in DHF
any studies proposed that the predominant patho-
hysiological mechanism of heart failure in DHF was
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n abnormal LV diastolic function [5,27,28,30—33].
elenovsky et al. suggested that the progression
f LV diastolic dysfunction played a key role in the
evelopment of heart failure symptoms in hyper-
ensive heart disease and normal LVEF [32]. They
ssessed LV systolic function using LVEF and tissue
oppler S′, but did not assess LV ICT. M-mode Teich-
olz and Doppler methods were used to assess the
V volume in their study instead of the standard
impson’s method. Therefore, their method for LV
ystolic function assessement seemed to be inap-
ropriate. In our study, the LV diastolic function
n ADD and DHF was signiﬁcantly disordered com-
ared to that of Control. We did not identify any
igniﬁcant differences in the degree of LV diastolic
ysfunction between ADD and DHF. We assessed the
V diastolic function using mitral ﬂow indices, TDI
ndices, E/E′, IRT, and the left atrial volume, the
ame methodology used in Melenovsky’s study.
tudy limitations
e compared the LV systolic function between ADD
nd DHF in different patient groups. In order to
larify the role of systolic dysfunction in the devel-
pment from ADD to DHF, it would be better to
xamine the same patient group. However, it takes
long time to accumulate such patients. The num-
er of patients with ADD was less than that with
HF.
onclusion
ur results revealed that the major difference
etween ADD and DHF was global and longitudi-
al LV systolic dysfunction and LV enlargement. This
tudy suggests that LV systolic dysfunction plays an
mportant role in the development of DHF.
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